PharmaCyte Biotech, Inc. Stock Performance

Open $0.40	Prev. Close $0.40	Circuit Range N/A
Day Range $0.40 - $0.40	Year Range $0.35 - $1.50	Volume 405
Average Traded $0.40

PharmaCyte Biotech, Inc. Share Price Today

As of 9 October 2026, PharmaCyte Biotech, Inc.'s share price is $0.40. The stock opened at $0.40, compared to its previous close of $0.40. During today's trading session, PharmaCyte Biotech, Inc.'s share price traded between $0.40 and $0.40, with an average price of $0.40. Over the past 52 weeks, the stock has recorded a high of $1.50 and a low of $0.35. In terms of performance, PharmaCyte Biotech, Inc.'s share price has declined by 47.29% over the last six months and is down 56.98% on a year-on-year basis.

PharmaCyte Biotech, Inc. Share Price Chart

$0.40$0.40

PharmaCyte Biotech, Inc. Stock Fundamentals & Key Indicators

Market Cap $2.93M	PE Ratio (TTM) N/A	Dividend Yield 7.48%
EPS (TTM) $-3.35	Revenue (TTM) $0.00	Return On Equity (TTM) -130.58%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY 31.24%

PharmaCyte Biotech, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$8.42	-$1.56	-$20.16	-$5.79
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	81.47%	-1192.31%	71.28%

PharmaCyte Biotech, Inc. Annual Profit & Loss

All figures in USD

Particulars	2023	2024	2025	2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$4.32	-$17.24	$23.36	-$23.21
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-299.07%	235.50%	-199.36%

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

PharmaCyte Biotech, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$0.40	$0.40	-8.47%
Sep 2026	$0.49	$0.44	-18.92%
Aug 2026	$0.57	$0.54	-5.44%
Jul 2026	$0.76	$0.57	-25.97%
Jun 2026	$0.81	$0.77	-5.87%
May 2026	$0.74	$0.82	+7.77%
Apr 2026	$0.71	$0.76	+15.00%
Mar 2026	$0.70	$0.66	-6.91%
Feb 2026	$0.80	$0.71	-12.68%
Jan 2026	$0.70	$0.81	+13.88%
Dec 2025	$0.75	$0.71	-7.40%
Nov 2025	$0.93	$0.77	-17.20%

PMCB Share Price FAQs

What is PharmaCyte Biotech, Inc. share price today?

PharmaCyte Biotech, Inc. share price today is $0.40 as on October 9, 2026 at 12:26 am IST.

What is the 52 week high and 52 week low of PharmaCyte Biotech, Inc. stock?

The 52 week high of PharmaCyte Biotech, Inc. stock is $1.50, while the 52 week low is $0.35 as of 9 Oct '26.

What is PMCB's market capitalisation today?

PMCB market capitalisation is $2.93M as of October 9, 2026, at 1:30 am IST.

What is PMCB's net income for the last quarter?

PMCB's net income for the last quarter is -5.79B USD.

What is the 5 year returns of PMCB?

The 5 year returns of PMCB is -85.81% as on 9 Oct '26.

What is the high & low stock price of PMCB today?

PMCB stock price hit a high of $0.40 and low of $0.40 as of 9 Oct '26.

Can I buy PMCB shares in India?

Yes. You can buy PMCB in India by opening an international trading account.